Safety and Efficacy of Beclomethasone Dipropionate in Patients At Least 12 Years Old With Asthma

Study Title
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
Teva Identifier
BDB-AS-304
ClinicalTrials.gov Identifier
NCT02040779
Study Status
Completed
Trial Condition(s)
Persistent Asthma
Interventions
Drug: Beclomethasone dipropionate breath-actuated inhaler | Drug: Placebo breath-actuated inhaler | Drug: albuterol/salbutamol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
December 26, 2013 - December 24, 2014
Phase
Phase 3

Study Type

Interventional